AVIDAC Trademark

Trademark Overview

On Tuesday, February 18, 2003, a trademark application was filed for AVIDAC with the United States Patent and Trademark Office. The USPTO has given the AVIDAC trademark a serial number of 78216195. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, December 17, 2006. This trademark is owned by Supergen, Inc.. The AVIDAC trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical compositions for treating cancer and immune disorders

General Information

Serial Number78216195
Word MarkAVIDAC
Filing DateTuesday, February 18, 2003
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, December 17, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 23, 2003

Trademark Statements

Goods and Servicespharmaceutical compositions for treating cancer and immune disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 10, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSupergen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDublin, CA 94568
Party NameSupergen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDublin, CA 94568

Trademark Events

Event DateEvent Description
Wednesday, February 28, 2007ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, February 28, 2007ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 31, 2006EXTENSION 5 GRANTED
Wednesday, May 31, 2006EXTENSION 5 FILED
Wednesday, May 31, 2006TEAS EXTENSION RECEIVED
Tuesday, February 14, 2006ASSIGNED TO EXAMINER
Friday, November 18, 2005EXTENSION 4 GRANTED
Friday, November 18, 2005EXTENSION 4 FILED
Friday, November 18, 2005TEAS EXTENSION RECEIVED
Wednesday, June 15, 2005EXTENSION 3 GRANTED
Wednesday, June 15, 2005EXTENSION 3 FILED
Wednesday, June 15, 2005TEAS EXTENSION RECEIVED
Wednesday, December 29, 2004EXTENSION 2 GRANTED
Wednesday, December 15, 2004EXTENSION 2 FILED
Wednesday, December 15, 2004TEAS EXTENSION RECEIVED
Wednesday, May 26, 2004EXTENSION 1 GRANTED
Tuesday, May 18, 2004EXTENSION 1 FILED
Tuesday, May 18, 2004TEAS EXTENSION RECEIVED
Monday, March 8, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 23, 2004PAPER RECEIVED
Tuesday, December 16, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 23, 2003PUBLISHED FOR OPPOSITION
Wednesday, September 3, 2003NOTICE OF PUBLICATION
Monday, August 11, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, July 26, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 26, 2003ASSIGNED TO EXAMINER

Related Keywords

avidac immune disorders cancer treating compositions pharmaceutical